Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Prevention of Seasonal Affective Disorder

ClinicalTrials.gov ID: NCT00046449

Public ClinicalTrials.gov record NCT00046449. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 7:15 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Placebo Controlled Study Evaluating The Effectivess Of Medication In Preventing Seasonal Affective Disorder

Study identification

NCT ID
NCT00046449
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
Not listed

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2002 (Type not available)
Primary completion
Jun 2003 (Actual)
Completion
Jun 2003 (Actual)
Last update posted
Jun 4, 2015

2002 – 2003

United States locations

U.S. sites
47
U.S. states
19
U.S. cities
42
Facility City State ZIP Site status
Study Site Homer Alaska 99603 —
Study Site New Haven Connecticut 06504-0605 —
Study Site Newark Delaware 19713 —
Study Site Wilmington Delaware 19808-1251 —
Study Site Washington D.C. District of Columbia 20016 —
Study Site Washington D.C. District of Columbia 20037 —
Study Site Boise Idaho 83704 —
Study SIte Chicago Illinois 60610 —
Study Site Chicago Illinois 60612 —
Study Site Hoffman Estates Illinois 60194 —
Study Site Libertyville Illinois 60048 —
Study SIte Northfield Illinois 60093 —
Study Site Schaumburg Illinois 60194 —
Study SIte Greenwood Indiana 46143 —
Study Site Indianapolis Indiana 45202 —
Study Site Florence Kentucky 41042 —
Study Site Wellesley Hills Massachusetts 02481 —
Study Site Okemos Michigan 48864 —
Study Site Royal Oak Michigan 48067 —
Study Site Minneapolis Minnesota 55454 —
Study Site Moorestown New Jersey 08057 —
Study Site Piscataway New Jersey 08854 —
Study Site Amityville New York 11701 —
Study Site Lawrence New York 11559 —
Study Site New York New York 10021 —
Study Site Olean New York 14760 —
Study Site Staten Island New York 10305 —
Study Site Williamsville New York 14221 —
Study Site Cincinnati Ohio 45219 —
Study Site Cleveland Ohio 44106 —
Study Site Cleveland Ohio 44121 —
Study Site Independence Ohio 44131 —
Study Site Lyndhurst Ohio 44124 —
Study Site Toledo Ohio 43623 —
Study Site Eugene Oregon 97401 —
Study Site Portland Oregon 97201 —
Study Site Portland Oregon 97209 —
Study Site Salem Oregon 97309 —
Study Site Allentown Pennsylvania 18104 —
Study Site Philadelphia Pennsylvania 19106 —
Study Site Philadelphia Pennsylvania 19107 —
Study Site Lincoln Rhode Island 02865-4208 —
Study Site Seattle Washington 98104 —
Study Site Madison Wisconsin 53719 —
Study Site Middleton Wisconsin 53562 —
Study Site Milwaukee Wisconsin 53226 —
Study Site West Allis Wisconsin 53227 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00046449, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 4, 2015 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00046449 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →